V. Balatti

Most-cited papers

1. tsRNA signatures in cancer

   V. Balatti, G. Nigita, Dario Veneziano, A. Drusco +21 more

   2017Proceedings of the National Academy of Sciences of the United States of America266 citations Open access

   Semantic Scholar

   Save

2. Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer

   Y. Pekarsky, V. Balatti, Alexey Palamarchuk, L. Rizzotto +7 more

   2016Proceedings of the National Academy of Sciences of the United States of America236 citations Open access

   Semantic Scholar

   Save

3. NOTCH1 mutations in CLL associated with trisomy 12.

   V. Balatti, A. Bottoni, Alexey Palamarchuk, H. Alder +4 more

   2012Blood208 citations Open access

   Semantic Scholar

   Save

4. Karyotype-specific microRNA signature in chronic lymphocytic leukemia.

   R. Visone, L. Rassenti, A. Veronese, C. Taccioli +10 more

   2009Blood205 citations Open access

   Semantic Scholar

   Save

5. BCL2 and miR-15/16: from gene discovery to treatment

   Y. Pekarsky, V. Balatti, C. Croce

   2017Cell Death and Differentiation175 citations Open access

   Semantic Scholar

   Save

6. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.

   R. Visone, A. Veronese, L. Rassenti, V. Balatti +6 more

   2011Blood139 citations Open access

   Semantic Scholar

   Save

7. Abstract 1122: In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation.

   D. Palmieri, L. De Luca, Jessica A. Consiglio, A. Rocci +16 more

   2013120 citations

   Semantic Scholar

   Save

8. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2

   M. Acunzo, G. Romano, D. Palmieri, A. Laganà +6 more

   2013Proceedings of the National Academy of Sciences of the United States of America108 citations Open access

   Semantic Scholar

   Save

9. miR-15b/16-2 deletion promotes B-cell malignancies

   Francesca Lovat, M. Fassan, Pierluigi Gasparini, L. Rizzotto +7 more

   2015Proceedings of the National Academy of Sciences of the United States of America103 citations Open access

   Semantic Scholar

   Save

10. MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma

    V. Balatti, Stefania Maniero, M. Ferracin, A. Veronese +4 more

    2011Journal of Thoracic Oncology91 citations Open access

    Semantic Scholar

    Save

11. Role of microRNA in chronic lymphocytic leukemia onset and progression

    V. Balatti, Yuri Pekarky, C. Croce

    2015Journal of Hematology & Oncology86 citations Open access

    Semantic Scholar

    Save

12. B-cell malignancies in microRNA Eμ-miR-17∼92 transgenic mice

    S. Sandhu, M. Fassan, S. Volinia, Francesca Lovat +3 more

    2013Proceedings of the National Academy of Sciences of the United States of America80 citations Open access

    Semantic Scholar

    Save

13. Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for Therapy.

    V. Balatti, Y. Pekarsky, C. Croce

    2017Advances in Cancer Research74 citations

    Semantic Scholar

    Save

14. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL)

    Alexey Palamarchuk, P. Yan, N. Zanesi, Linan Wang +11 more

    2012Proceedings of the National Academy of Sciences of the United States of America73 citations Open access

    Semantic Scholar

    Save

15. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia

    V. Balatti, L. Rizzotto, Cecelia R. Miller, Alexey Palamarchuk +11 more

    2015Proceedings of the National Academy of Sciences of the United States of America72 citations Open access

    Semantic Scholar

    Save

16. Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer

    N. H. Farina, S. Scalia, C. Adams, De-Li Hong +8 more

    2020Journal of Cellular Physiology69 citations Open access

    Semantic Scholar

    Save

17. Mutated β-catenin evades a microRNA-dependent regulatory loop

    A. Veronese, R. Visone, Jessica A. Consiglio, M. Acunzo +13 more

    2011Proceedings of the National Academy of Sciences of the United States of America62 citations Open access

    Semantic Scholar

    Save

18. Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia

    Dario Veneziano, L. Tomasello, V. Balatti, Alexey Palamarchuk +4 more

    2019Proceedings of the National Academy of Sciences of the United States of America60 citations Open access

    Semantic Scholar

    Save

19. Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer

    A. La Ferlita, S. Alaimo, Dario Veneziano, G. Nigita +4 more

    2019Database J. Biol. Databases Curation55 citations Open access

    Semantic Scholar

    Save

20. MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia

    L. Rassenti, V. Balatti, E. Ghia, Alexey Palamarchuk +6 more

    2017Proceedings of the National Academy of Sciences of the United States of America53 citations Open access

    Semantic Scholar

    Save

21. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia

    R. Visone, A. Veronese, V. Balatti, C. Croce

    2012OncoTarget50 citations Open access

    Semantic Scholar

    Save

22. tRNA-derived fragments (tRFs) in cancer

    Y. Pekarsky, V. Balatti, C. Croce

    2022Journal of cell communication and signaling47 citations Open access

    Semantic Scholar

    Save

23. Novel mechanisms of regulation of miRNAs in CLL

    V. Balatti, M. Acunzo, Yuri Pekarky, C. Croce

    2016Trends in Cancer42 citations Open access

    Semantic Scholar

    Save

24. A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model.

    N. Zanesi, V. Balatti, Jesse D. Riordan, Aaron Burch +7 more

    2013Blood36 citations Open access

    Semantic Scholar

    Save

25. miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients.

    V. Balatti, L. Tomasello, L. Rassenti, Dario Veneziano +6 more

    2018Blood33 citations Open access

    Semantic Scholar

    Save

26. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution.

    Cecilia Pancaldi, V. Balatti, R. Guaschino, F. Vaniglia +4 more

    2009Journal of Infection32 citations

    Semantic Scholar

    Save

27. MicroRNA dysregulation and multi-targeted therapy for cancer treatment

    V. Balatti, C. Croce

    2019Advances in Biological Regulation31 citations Open access

    Semantic Scholar

    Save

28. miR deregulation in CLL

    V. Balatti, Yuri Pekarky, L. Rizzotto, C. Croce

    2013Advances in Experimental Medicine and Biology26 citations Open access

    Semantic Scholar

    Save

29. Gram-Negative Bacterial Lipopolysaccharide Retention by a Positively Charged New-Generation Filter

    I. Bononi, V. Balatti, S. Gaeta, M. Tognon

    2008Applied and Environmental Microbiology26 citations Open access

    Semantic Scholar

    Save

30. Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia

    F. Pepe, V. Balatti

    2020Journal of Clinical Medicine25 citations Open access

    Semantic Scholar

    Save

31. Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

    F. Pichiorri, D. Palmieri, L. De Luca, Jessica A. Consiglio +18 more

    2017Journal of Experimental Medicine23 citations Open access

    Semantic Scholar

    Save

32. Trisomy 12 CLLs progress through NOTCH1 mutations

    V. Balatti, S. Lerner, L. Rizzotto, L. Rassenti +8 more

    2012Leukemia22 citations Open access

    Semantic Scholar

    Save

33. MiR-155-targeted IcosL controls tumor rejection

    E. Tili, Hajime Otsu, Teresa L Commisso, Alexey Palamarchuk +4 more

    2024Proceedings of the National Academy of Sciences of the United States of America17 citations Open access

    Semantic Scholar

    Save

34. Novel insights in molecular mechanisms of CLL.

    N. Zanesi, V. Balatti, A. Bottoni, C. Croce +1 more

    2012Current pharmaceutical design17 citations

    Semantic Scholar

    Save

35. MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene

    V. Balatti, S. Oghumu, A. Bottoni, K. Maharry +5 more

    2018Head and Neck Pathology15 citations Open access

    Semantic Scholar

    Save

36. Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene.

    M. Acunzo, G. Romano, D. Wernicke, V. Balatti +5 more

    2014Blood14 citations Open access

    Semantic Scholar

    Save

37. Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia

    A. La Ferlita, G. Nigita, L. Tsyba, Alexey Palamarchuk +8 more

    2023Proceedings of the National Academy of Sciences of the United States of America12 citations Open access

    Semantic Scholar

    Save

38. HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia

    S. Pagotto, A. Veronese, Alessandra Soranno, V. Balatti +11 more

    2019Cancers12 citations Open access

    Semantic Scholar

    Save

39. A large fraction of trisomy 12, 17p−, and 11q− CLL cases carry unidentified microdeletions of miR-15a/16-1

    F. Pepe, L. Rassenti, Y. Pekarsky, J. Labanowska +5 more

    2022Proceedings of the National Academy of Sciences of the United States of America10 citations Open access

    Semantic Scholar

    Save

40. Small Non-Coding RNAs in Leukemia

    V. Balatti, C. Croce

    2022Cancers9 citations Open access

    Semantic Scholar

    Save

41. Primary intrathyroidal paraganglioma: histopathology and novel molecular alterations.

    S. Costinean, V. Balatti, A. Bottoni, M. Old +2 more

    2012Human Pathology9 citations

    Semantic Scholar

    Save

42. miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas

    E. Tili, Teresa L Commisso, V. Balatti, J. Michaille +2 more

    2025Proceedings of the National Academy of Sciences of the United States of America7 citations Open access

    Semantic Scholar

    Save

43. Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study

    A. Ramassone, A. D’Argenio, A. Veronese, Alessio Basti +18 more

    2019Journal of Hematology & Oncology5 citations Open access

    Semantic Scholar

    Save

44. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

    F. Pichiorri, Dario Palmieri, L. De Luca, Jessica A. Consiglio +18 more

    2013Journal of Experimental Medicine5 citations Open access

    Semantic Scholar

    Save

45. Role of Ts-RNAs in CLL

    V. Balatti, Alexey Palamarchuk, L. Rizzotto, Dario Veneziano +6 more

    20164 citations

    Semantic Scholar

    Save

46. Gradual Rarefaction of Hematopoietic Precursors and Atrophy in a Depleted microRNA 29a, b and c Environment

    L. Kauffman, V. Balatti, L. Cascione, P. Fadda +3 more

    2015PLoS ONE3 citations Open access

    Semantic Scholar

    Save

47. B-Cell Lymphoma In Eu-Mir-17~92 Transgenic Mice

    S. Sandhu, Reid Neinast, V. Balatti, Francesca Lovat +4 more

    20101 citations

    Semantic Scholar

    Save

48. Glioblastoma in a patient with professional exposure to the oncogenic polyomavirus SV40

    F. Martini, V. Balatti, F. Lupidi, M. Gerosa +1 more

    20071 citations

    Semantic Scholar

    Save

49. Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

    Flavia Pichiorri, Dario Palmieri, L. De Luca, Jessica A. Consiglio +18 more

    2026Journal of Experimental Medicine0 citations Open access

    Semantic Scholar

    Save

50. LYMPHOID NEOPLASIA Translocation t ( 2 ; 11 ) in CLL cells results in CXCR 4 / MAML 2 fusion oncogene

    M. Acunzo, G. Romano, D. Wernicke, V. Balatti +5 more

    20140 citations

    Semantic Scholar

    Save